Conference Coverage

Levothyroxine may increase mortality in older patients

Publish date: April 4, 2018

 

REPORTING FROM ENDO 2018


Despite these limitations, Dr. Meyerovitch and his team stressed the need for more research before continuing to recommend this treatment to their elderly patients.

Dr. Meyerovitch reported no relevant financial disclosures.

Source: Meyerovitch J et al. ENDO 2018 Abstract OR34-2.

Pages

Recommended Reading

Long-term methimazole therapy improves Graves disease remission rate
MDedge Family Medicine
Patients prefer higher dose of levothyroxine despite lack of objective benefit
MDedge Family Medicine
Autoimmune endocrinopathies spike after celiac disease diagnosis
MDedge Family Medicine
Generic, brand-name levothyroxine have similar cardiovascular outcomes
MDedge Family Medicine
New and improved classifiers may sharpen thyroid nodule diagnosis
MDedge Family Medicine
Iodine deficiency linked to delay in pregnancy
MDedge Family Medicine
PCOS may influence the diversity of the gut microbiome
MDedge Family Medicine
Study: Natpara slightly boosts health-related QoL in hypoparathyroidism
MDedge Family Medicine
Surgery indicates higher survival with adrenal cortical carcinoma
MDedge Family Medicine
When it comes to thyroid cancer follow-up, serum microRNA profiles have earned new respect
MDedge Family Medicine